Cargando…
Jadomycins: A potential chemotherapy for multi‐drug resistant metastatic breast cancer
Breast cancer causes the most cancer fatalities in women worldwide. Approximately one‐third of breast cancers metastasize, or spread from primary tumors to other tissues, and have a 70% 5‐year mortality rate. Current breast cancer treatments like doxorubicin and paclitaxel become ineffective when br...
Autores principales: | Bonitto, Esther P., McKeown, Brendan T., Goralski, Kerry B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551564/ https://www.ncbi.nlm.nih.gov/pubmed/34708587 http://dx.doi.org/10.1002/prp2.886 |
Ejemplares similares
-
Jadomycin breast cancer cytotoxicity is mediated by a copper-dependent, reactive oxygen species–inducing mechanism
por: Hall, Steven R, et al.
Publicado: (2015) -
More Than an Adipokine: The Complex Roles of Chemerin Signaling in Cancer
por: Goralski, Kerry B., et al.
Publicado: (2019) -
Streptomyces venezuelae ISP5230 Maintains Excretion of Jadomycin upon Disruption of the MFS Transporter JadL Located within the Natural Product Biosynthetic Gene Cluster
por: Forget, Stephanie M., et al.
Publicado: (2017) -
Adult ileocolic intussusception presenting as small bowel metastatic melanoma
por: Bastawrous, Sarah, et al.
Publicado: (2015) -
AQ4N: a new approach to hypoxia-activated cancer chemotherapy
por: Patterson, L H, et al.
Publicado: (2000)